Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit
Balance at beginning (in shares) at Dec. 31, 2023	130,648,426
Balance at beginning at Dec. 31, 2023	$ 162,147
Changes in Convertible Preferred Stock
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)	(130,648,426)
Conversion of convertible preferred stock into common stock upon initial public offering	$ (162,147)
Balance at ending (in shares) at Dec. 31, 2024	0
Balance at ending at Dec. 31, 2024	$ 0
Balance at beginning (in shares) at Dec. 31, 2023		460,704
Balance at beginning at Dec. 31, 2023	(123,730)	$ 1	$ 36,231	$ (159,962)
Changes in Stockholders' Deficit
Vesting of restricted common stock (in shares)		58,300
Stock option exercises (in shares)		513,781
Stock option exercises	113		113
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)		11,648,582
Conversion of convertible preferred stock into common stock upon initial public offering	162,147	$ 1	162,146
Issuance of common stock upon initial public offering and private placement and registered direct offering, net of offering costs (in shares)		7,463,762
Issuance of common stock upon initial public offering and private placement and registered direct offering, net of offering costs	72,373		72,373
Stock-based compensation expense	4,032		4,032
Net loss	$ (51,791)			(51,791)
Balance at ending (in shares) at Dec. 31, 2024	20,145,129	20,145,129
Balance at ending at Dec. 31, 2024	$ 63,144	$ 2	274,895	(211,753)
Balance at ending (in shares) at Dec. 31, 2025	0
Balance at ending at Dec. 31, 2025	$ 0
Changes in Stockholders' Deficit
Vesting of restricted common stock (in shares)		15,943
Stock option exercises (in shares)	24,128	24,127
Stock option exercises	$ 51		51
Issuance of common stock upon initial public offering and private placement and registered direct offering, net of offering costs (in shares)		31,717,415
Issuance of common stock upon initial public offering and private placement and registered direct offering, net of offering costs	57,313	$ 4	57,309
Issuance of pre-funded warrants in private placement, net of issuance costs	3,601		3,601
Stock-based compensation expense	3,998		3,998
Net loss	$ (80,403)			(80,403)
Balance at ending (in shares) at Dec. 31, 2025	51,902,614	51,902,614
Balance at ending at Dec. 31, 2025	$ 47,704	$ 6	$ 339,854	$ (292,156)